UK markets close in 2 hours 29 minutes

Yuhan Corporation (000100.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
75,000.00+6,200.00 (+9.01%)
At close: 03:30PM KST

Yuhan Corporation

74, Noryangjin-ro
Daebang-dong Dongjak-gu
Seoul
South Korea
82 2 828 0181
https://www.yuhan.co.kr

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Wook-Je ChoPresident, CEO & Executive DirectorN/AN/A1955
Mr. Jae-Kyo KimExecutive Vice Director & Head of the Pharmaceutical Business Mgnt. Dept.N/AN/A1967
Mr. Byung-Man LeeExecutive VP & Head of the Pharmaceutical Business DivisionN/AN/A1958
Yeul-Hong KimExecutive DirectorN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.

Description

Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally. It also manufactures and sells animal feed and health functional food. The company was founded in 1926 and is headquartered in Seoul, South Korea.

Corporate governance

Yuhan Corporation’s ISS governance QualityScore as of 1 June 2024 is 4. The pillar scores are Audit: 1; Board: 6; Shareholder rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.